Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
The conclave brought together over 1,000 delegates from across India and internationally
Move to accelerate cancer care expansion across India
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
With the expansion, the hospital’s total bed capacity will rise from 380 to 539 beds
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
Subscribe To Our Newsletter & Stay Updated